FNY Investment Advisers’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,000
Closed -$308K 1058
2024
Q4
$308K Buy
+25,000
New +$286K 0.16% 127
2023
Q3
Sell
-5,000
Closed -$69K 787
2023
Q2
$69K Buy
+5,000
New +$85.2K 0.09% 139

Other funds holding CDMO

FNY Investment Advisers's CDMO Position: Q1 2025 in Review

FNY Investment Advisers sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 25,000 shares — an estimated $308K sold.

FNY Investment Advisers first reported a position in CDMO in Q2 2023 and held it in 2 quarters. The position peaked at $308K in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • FNY Investment Advisers reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 25,000 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $308K.
  • FNY Investment Advisers first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • FNY Investment Advisers's Avid Bioservices, Inc. Common Stock position peaked at $308K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on FNY Investment Advisers's 13F filing for Q1 2025, filed 17 Apr 2025.